Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Mucositis × Laser Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Squamous Intraepithelial Lesions 1 Papillomavirus Infections 1 Mucositis 1 Hematologic Neoplasms 1 HIV Infections 1 Gallbladder Neoplasms 1 Breast Carcinoma In Situ 1 Bile Duct Neoplasms 1 Anus Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Radiotherapy 2 Glutamine 2 Fibroblast Growth Factor 7 2 oxycodone-acetaminophen 1 cyclohexaneacetic acid 1 acetaminophen, hydrocodone drug combination 1 Surveys and Questionnaires 1 Sucralfate 1 Standard of Care 1 Passive Cutaneous Anaphylaxis 1 Pain Management 1 Neck Dissection 1 Morphine 1 Methods 1 Methadone 1 Laser Therapy 1 Ketamine 1 Ibuprofen 1 Hydromorphone 1 Gabapentin 1 Fentanyl 1 Educational Status 1 Early Intervention, Educational 1 Doxepin 1 Cisplatin 1 Benzydamine 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02696408 2020-01-29

STOP MUCITES

Institut de Cancérologie de la Loire

Phase 3 Completed

OtherOther hematologic neoplasm

Hematologic Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡